2. Signaling Pathways
  3. Cytoskeleton
  4. Claudin
  5. CLDN1 Isoform
  6. CLDN1 Inhibitor

CLDN1 Inhibitor

CLDN1 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P990045
    Lixudebart
    		Inhibitor 98.88%
    Lixudebart (ALE.F02) is a humanized immunoglobulin G1-kappa, anti-CLDN1 monoclonal antibody. Lixudebart disrupts CLDN1 interactions with CD44 and MMP14, reduces renal macrophage infiltration, epithelial activation, and urinary albumin-to-creatinine ratio, and attenuates glomerulosclerosis. Lixudebart can be used for the research of focal segmental glomerulosclerosis.